The competitor in Europe. Vaktsina "Gam-Kovid-Vak" became the main rival in the market of vaccines

EU does not hurry to assume Vaktsina "Gam-Kovid-Vak" on the market because of fear that preparations already approved by it will not sustain the competition to Russian. The director of FEDERAL STATE-FINANCED INSTITUTION "NITSEM NAMED AFTER N. F. GAMALEI" MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION Alexander Leonidovich Gintsburg with whom many Europeans agree. They are afraid of side effects from already applied in EU preparations. Meanwhile in Europe catches more and more people, and the authorities declare national lokdauny...